By Colin Kellaher
Disc Medicine’s chief financial officer, Joanne Bryce, is leaving the clinical-stage biopharmaceutical company.
The Watertown, Mass., company on Monday said it has launched a search for a successor to Bryce, who became chief financial officer in September 2021 after serving as a part-time consultant acting as finance chief since November 2017.
Disc said Bryce plans to remain with the company and oversee her current duties until a successor has been identified.
Write to Colin Kellaher at [email protected]
Read the full article here